» Articles » PMID: 25557204

IL-17A Activates ERK1/2 and Enhances Differentiation of Oligodendrocyte Progenitor Cells

Overview
Journal Glia
Specialty Neurology
Date 2015 Jan 6
PMID 25557204
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

Inflammatory signals present in demyelinated multiple sclerosis lesions affect the reparative remyelination process conducted by oligodendrocyte progenitor cells (OPCs). Interferon-γ (IFN-γ), tumor necrosis factor-α (TNF-α), and interleukin (IL)-6 have differing effects on the viability and growth of OPCs, however the effects of IL-17A are largely unknown. Primary murine OPCs were stimulated with IL-17A and their viability, proliferation, and maturation were assessed in culture. IL-17A-stimulated OPCs exited the cell cycle and differentiated with no loss in viability. Expression of the myelin-specific protein, proteolipid protein, increased in a cerebellar slice culture assay in the presence of IL-17A. Downstream, IL-17A activated ERK1/2 within 15 min and induced chemokine expression in 2 days. These results demonstrate that IL-17A exposure stimulates OPCs to mature and participate in the inflammatory response.

Citing Articles

Interaction between Th17 and central nervous system in multiple sclerosis.

Lai S, Wu X, Liu Y, Liu B, Wu H, Ma K Brain Behav Immun Health. 2025; 43():100928.

PMID: 39845807 PMC: 11751430. DOI: 10.1016/j.bbih.2024.100928.


From placenta to the foetus: a systematic review of in vitro models of stress- and inflammation-induced depression in pregnancy.

Kirkpatrick M, Mandal G, Elhadidy I, Mariani N, Priestley K, Pariante C Mol Psychiatry. 2024; .

PMID: 39639175 DOI: 10.1038/s41380-024-02866-1.


The Role of Inflammatory Cascade and Reactive Astrogliosis in Glial Scar Formation Post-spinal Cord Injury.

Bhatt M, Sharma M, Das B Cell Mol Neurobiol. 2024; 44(1):78.

PMID: 39579235 PMC: 11585509. DOI: 10.1007/s10571-024-01519-9.


Neuroinflammatory Proteins in Huntington's Disease: Insights into Mechanisms, Diagnosis, and Therapeutic Implications.

Li X, Tong H, Xu S, Zhou G, Yang T, Yin S Int J Mol Sci. 2024; 25(21).

PMID: 39519337 PMC: 11546928. DOI: 10.3390/ijms252111787.


Oligodendrocytes in central nervous system diseases: the effect of cytokine regulation.

Zhang C, Qiu M, Fu H Neural Regen Res. 2024; 19(10):2132-2143.

PMID: 38488548 PMC: 11034588. DOI: 10.4103/1673-5374.392854.


References
1.
Wolswijk G . Oligodendrocyte survival, loss and birth in lesions of chronic-stage multiple sclerosis. Brain. 1999; 123 ( Pt 1):105-15. DOI: 10.1093/brain/123.1.105. View

2.
Maeda Y, Solanky M, Menonna J, Chapin J, Li W, Dowling P . Platelet-derived growth factor-alpha receptor-positive oligodendroglia are frequent in multiple sclerosis lesions. Ann Neurol. 2001; 49(6):776-85. DOI: 10.1002/ana.1015. View

3.
Lock C, Hermans G, Pedotti R, Brendolan A, Schadt E, Garren H . Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat Med. 2002; 8(5):500-8. DOI: 10.1038/nm0502-500. View

4.
Vela J, Molina-Holgado E, Arevalo-Martin A, Almazan G, Guaza C . Interleukin-1 regulates proliferation and differentiation of oligodendrocyte progenitor cells. Mol Cell Neurosci. 2002; 20(3):489-502. DOI: 10.1006/mcne.2002.1127. View

5.
Valerio A, Ferrario M, Dreano M, Garotta G, Spano P, Pizzi M . Soluble interleukin-6 (IL-6) receptor/IL-6 fusion protein enhances in vitro differentiation of purified rat oligodendroglial lineage cells. Mol Cell Neurosci. 2002; 21(4):602-15. DOI: 10.1006/mcne.2002.1208. View